Connecting Medtech leaders with insights, partnerships, and deal-making opportunities.
Keep updated on the Medtech industry including speaker and session insights focused on funding strategies, European versus global market access, commercial scaling and strategic partnerships for early-stage companies.
Session Spotlights
Strategic Partnerships: When and How to Engage with Large Medtech Companies
Join business development leaders and key partnerships stakeholders as they examine when and how emerging companies should pursue relationships with established industry players and what makes them successful for both parties, drawing on real-world examples of both successful and failed partnerships.
Crossing the Pond: Positioning of the US in the Global Market and Strategies for Market Access
Despite increasing global opportunities, the United States remains the world's largest and most lucrative medical device market, but also one of the most challenging to enter successfully; What are the practical considerations from reimbursement strategy to distribution channel selection? What are common pitfalls to watch out for? Join this session to find out!
Pushing The Boundaries: How Far can AI Technologies Take us in Healthcare?
Artificial Intelligence is becoming a transformative force in medical technology, but what are its limitations - if any? Drawing on real-world implementations in clinical settings, this engaging panel discussion will highlight how AI is enhancing diagnostic accuracy, optimizing device performance, and creating new possibilities for personalized medicine, but will also address challenges that companies must navigate to stay ahead.
Medtech Speaker Snapshot
FAQs
What are the key themes covered in the the Medtech Leaders sessions?
The Medtech Leaders track is designed to support and accelerate the growth of innovative medical device, diagnostic, surgical‑robotics and wearable/women’s‑health companies by connecting them with investors, strategic partners and expert knowledge. Key themes include:
- Access to Capital & Strategic Partnerships
- Regulatory & Global Market Access
- Technology Innovation & Commercialisation
- Scaling & Leadership
- Deal‑Making & Growth Strategy
What is the Medtech CEO Forum?
Taking place on Day One, the MedTech CEO Forum is a closed-door, discussion-based session for CEOs and founders of early-stage MedTech companies. Participants share real-world challenges and strategies in a candid environment, under Chatham House rules. Attendees include pre-revenue to early-commercialisation MedTech CEOs, founders, and C-suite leaders seeking peer insights, growth strategies, and solutions to scaling challenges.
Are global expansion strategies covered in Medtech sessions?
Yes - Sessions explore how early- and growth-stage MedTech companies can successfully enter and scale in international markets. Topics include navigating complex regulatory pathways (like FDA vs. EU MDR), tailoring go-to-market strategies for new regions, and leveraging innovation hubs across Europe and beyond.
The session “Where Next?” specifically addresses how European MedTech's can enter global markets, considering regulatory, reimbursement, and commercial factors.
How are exit strategies discussed?
Exit strategies are addressed through panels and discussions on preparing for acquisitions, timing your exit, and aligning funding rounds to maximize valuation. These sessions provide practical guidance on positioning your company for a successful sale or IPO throughout the growth journey.
The session “The Acquisition Playbook” explores how to prepare your company for an acquisition, including timing, deal prep, and aligning internal processes.
Is the investor view represented at Medtech?
Definitely! Investors are featured across all three days, sharing perspectives on funding strategy, scaling, valuations, outsourcing, and exit planning. Panels include both venture and strategic investors actively backing MedTech innovation.
